Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Availability of troponin testing for cardiac patients in New Zealand 2002 to 2011: implications for patient care.

Latif M, Ellis C, Chataline A, Gamble G, Kyle C, White H.

N Z Med J. 2012 Jun 29;125(1357):44-61.

PMID:
22854360
2.

Troponin T or troponin I or CK-MB (or none?).

Collinson PO.

Eur Heart J. 1998 Nov;19 Suppl N:N16-24.

PMID:
9857934
3.

Sensitive and high sensitivity next generation cardiac troponin assays: more than just a name.

Christenson RH, Phillips D.

Pathology. 2011 Apr;43(3):213-9. doi: 10.1097/PAT.0b013e328343762d. Review.

PMID:
21436630
4.

Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms.

Vikenes K, Andersen KS, Melberg T, Farstad M, Nordrehaug JE.

Am J Cardiol. 2010 Sep 15;106(6):780-6. doi: 10.1016/j.amjcard.2010.04.038. Epub 2010 Aug 1.

PMID:
20816117
5.
6.

Current trends in diagnostic biomarkers of acute coronary syndrome.

Moe KT, Wong P.

Ann Acad Med Singapore. 2010 Mar;39(3):210-5. Review.

7.

Biomarkers in acute coronary syndrome and percutaneous coronary intervention.

Searle J, Danne O, Müller C, Mockel M.

Minerva Cardioangiol. 2011 Jun;59(3):203-23. Review.

PMID:
21516070
8.

Outcomes associated with small changes in normal-range cardiac markers.

McMullin N, Lindsell CJ, Lei L, Mafi J, Jois-Bilowich P, Anantharaman V, Pollack CV Jr, Hollander JE, Gibler WB, Hoekestra JW, Diercks D, Peacock WF; EMCREG i*trACS Investigators.

Am J Emerg Med. 2011 Feb;29(2):162-7. doi: 10.1016/j.ajem.2009.08.016. Epub 2010 Mar 9.

PMID:
20825781
9.
10.

Interpreting cardiac troponin results from highly sensitive assays in patients with chronic kidney disease: acute coronary syndromes and beyond.

End C, Seliger SL, deFilippi CR.

Coron Artery Dis. 2013 Dec;24(8):720-3. doi: 10.1097/MCA.0000000000000046. Review.

PMID:
24128885
11.

Troponin assays for the diagnosis of myocardial infarction and acute coronary syndrome: where do we stand?

Eisenman A.

Expert Rev Cardiovasc Ther. 2006 Jul;4(4):509-14. Review.

PMID:
16918269
12.

Cardiac markers: present and future.

Plebani M, Zaninotto M.

Int J Clin Lab Res. 1999;29(2):56-63. Review.

PMID:
10436262
13.

Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach: the North Wuerttemberg and Berlin Infarction Study-II (NOBIS-II).

Möckel M, Müller R, Vollert J, Müller C, Danne O, Gareis R, Störk T, Dietz R, Koenig W.

Clin Res Cardiol. 2007 Sep;96(9):604-12. Epub 2007 Jun 27.

PMID:
17593313
14.
15.

Are all troponin assays equivalent in the emergency department?

Eisenman A, Rusetski V, Avital D, Stolero J, Snitkovsky T.

Singapore Med J. 2005 Jul;46(7):325-7.

16.

Cardiac troponin T concentrations above the 99th percentile value as measured by a new high-sensitivity assay predict long-term prognosis in patients with acute coronary syndromes undergoing routine early invasive strategy.

Celik S, Giannitsis E, Wollert KC, Schwöbel K, Lossnitzer D, Hilbel T, Lehrke S, Zdunek D, Hess A, Januzzi JL, Katus HA.

Clin Res Cardiol. 2011 Dec;100(12):1077-85. doi: 10.1007/s00392-011-0344-x. Epub 2011 Jul 27.

PMID:
21792561
17.

The use of troponin in general practice.

Aldous S, Gent P, McGeoch G, Nicholson D.

N Z Med J. 2012 Jun 29;125(1357):36-43.

PMID:
22854359
18.

The need for a point of care testing: an evidence-based appraisal.

Collinson PO.

Scand J Clin Lab Invest Suppl. 1999;230:67-73.

PMID:
10389204
19.

Detection of myocardial damage - are the troponins the ultimate solution?

Lindahl B.

Scand Cardiovasc J. 2001 Sep;35(4):229-32.

PMID:
11759115
20.

The usage patterns of cardiac bedside markers employing point-of-care testing for troponin in non-ST-segment elevation acute coronary syndrome: results from CRUSADE.

Takakuwa KM, Ou FS, Peterson ED, Pollack CV Jr, Peacock WF, Hoekstra JW, Ohman EM, Gibler WB, Blomkalns AL, Roe MT.

Clin Cardiol. 2009 Sep;32(9):498-505. doi: 10.1002/clc.20626.

Supplemental Content

Support Center